Fever of unknown origin other diagnostic studies: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 16: | Line 16: | ||
[[Positron emission tomography]] using radioactively labelled [[fluorodeoxyglucose]] (FDG) has been reported to have a [[Sensitivity (tests)|sensitivity]] of 84% and a [[Specificity (tests)| specificity]] of 86% for localizing the nidus of fever of unknown origin.<ref>{{cite journal | author = Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W | title = Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. | journal = Eur J Nucl Med. | volume = 27| issue = 11 | pages = 1617-25 | year = 2000 | id = PMID 11105817}}</ref> | [[Positron emission tomography]] using radioactively labelled [[fluorodeoxyglucose]] (FDG) has been reported to have a [[Sensitivity (tests)|sensitivity]] of 84% and a [[Specificity (tests)| specificity]] of 86% for localizing the nidus of fever of unknown origin.<ref>{{cite journal | author = Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W | title = Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. | journal = Eur J Nucl Med. | volume = 27| issue = 11 | pages = 1617-25 | year = 2000 | id = PMID 11105817}}</ref> | ||
==Other Diagnostic Studies== | |||
Invasive techniques (biopsy and laparotomy for pathological and bacteriological examination) may be required to obtain a definitive diagnosis.<ref name="Mandell">[http://www.ppidonline.com/ Mandell's Principles and Practices of Infection Diseases] 6th Edition (2004) by Gerald L. Mandell MD, MACP, John E. Bennett MD, Raphael Dolin MD, ISBN 0-443-06643-4 · Hardback · 4016 Pages Churchill Livingstone </ref><ref name="Harrison">[http://books.mcgraw-hill.com/medical/harrisons/ Harrison's Principles of Internal Medicine] 16th Edition, The McGraw-Hill Companies, ISBN 0-07-140235-7</ref><ref name="Oxford"> [http://www.oup.com/us/catalog/general/subject/Medicine/PrimaryCare/?ci=0192629220&view=usa The Oxford Textbook of Medicine] Edited by David A. Warrell, Timothy M. Cox and John D. Firth with Edward J. Benz, Fourth Edition (2003), Oxford University Press, ISBN 0-19-262922-0</ref> | Invasive techniques (biopsy and laparotomy for pathological and bacteriological examination) may be required to obtain a definitive diagnosis.<ref name="Mandell">[http://www.ppidonline.com/ Mandell's Principles and Practices of Infection Diseases] 6th Edition (2004) by Gerald L. Mandell MD, MACP, John E. Bennett MD, Raphael Dolin MD, ISBN 0-443-06643-4 · Hardback · 4016 Pages Churchill Livingstone </ref><ref name="Harrison">[http://books.mcgraw-hill.com/medical/harrisons/ Harrison's Principles of Internal Medicine] 16th Edition, The McGraw-Hill Companies, ISBN 0-07-140235-7</ref><ref name="Oxford"> [http://www.oup.com/us/catalog/general/subject/Medicine/PrimaryCare/?ci=0192629220&view=usa The Oxford Textbook of Medicine] Edited by David A. Warrell, Timothy M. Cox and John D. Firth with Edward J. Benz, Fourth Edition (2003), Oxford University Press, ISBN 0-19-262922-0</ref> | ||
| Line 23: | Line 23: | ||
An infectious etiology is likely if abatement of fever occurs after the administration of antibiotics. Therapeutic trials of antimicrobial agents may be considered if other techniques fail to disclose the cause of FUO.<ref name="Mandell"/> | An infectious etiology is likely if abatement of fever occurs after the administration of antibiotics. Therapeutic trials of antimicrobial agents may be considered if other techniques fail to disclose the cause of FUO.<ref name="Mandell"/> | ||
==Naproxen test== | ===Naproxen test=== | ||
The administration of [[naproxen]] can be used to distinguish neoplastic fever from other etiologies of FUO. | The administration of [[naproxen]] can be used to distinguish neoplastic fever from other etiologies of FUO. | ||
Revision as of 16:11, 24 March 2015
|
Resident Survival Guide |
|
Fever of unknown origin Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fever of unknown origin other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Fever of unknown origin other diagnostic studies |
|
Fever of unknown origin other diagnostic studies in the news |
|
Risk calculators and risk factors for Fever of unknown origin other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: febris continua e causa ignota; febris e causa ignota; febris E.C.I.; fever/pyrexia of obscured/undetermined/uncertain/unidentifiable/unknown focus/origin/source; fever/pyrexia without a focus/origin/source; FUO; PUO
Imaging Studies
Echocardiography should be performed when suspecting endocarditis.
Hepatobiliary pathology may be detected by abdominal ultrasonography. An abdominal CT scan may show infection or malignancy of the visceral organs.
Positron emission tomography using radioactively labelled fluorodeoxyglucose (FDG) has been reported to have a sensitivity of 84% and a specificity of 86% for localizing the nidus of fever of unknown origin.[1]
Other Diagnostic Studies
Invasive techniques (biopsy and laparotomy for pathological and bacteriological examination) may be required to obtain a definitive diagnosis.[2][3][4]
Defervescence within 72 hours of discontinuing medication indicates drug fever.
An infectious etiology is likely if abatement of fever occurs after the administration of antibiotics. Therapeutic trials of antimicrobial agents may be considered if other techniques fail to disclose the cause of FUO.[2]
Naproxen test
The administration of naproxen can be used to distinguish neoplastic fever from other etiologies of FUO.
At a dosage of 375 mg twice daily, naproxen demonstrated no antipyretic activity against fever in patients with occult infection. Defervescence within 12 hours occurs in almost all patients with neoplastic fever. The naproxen test is considered positive when there is a rapid or sustained abatement of fever during the 3 days of the trial period. Fever recurs after discontinuation of naproxen in patients with neoplasms.[5]
References
- ↑ Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W (2000). "Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET". Eur J Nucl Med. 27 (11): 1617–25. PMID 11105817.
- ↑ 2.0 2.1 Mandell's Principles and Practices of Infection Diseases 6th Edition (2004) by Gerald L. Mandell MD, MACP, John E. Bennett MD, Raphael Dolin MD, ISBN 0-443-06643-4 · Hardback · 4016 Pages Churchill Livingstone
- ↑ Harrison's Principles of Internal Medicine 16th Edition, The McGraw-Hill Companies, ISBN 0-07-140235-7
- ↑ The Oxford Textbook of Medicine Edited by David A. Warrell, Timothy M. Cox and John D. Firth with Edward J. Benz, Fourth Edition (2003), Oxford University Press, ISBN 0-19-262922-0
- ↑ Chang, J. C. (1987-03). "How to differentiate neoplastic fever from infectious fever in patients with cancer: usefulness of the naproxen test". Heart & Lung: The Journal of Critical Care. 16 (2): 122–127. ISSN 0147-9563. PMID 3028981. Check date values in:
|date=(help)